First-of-its-kind blood volume measurement objectively confirms sample collection quality in every bottle processed, improving confidence in blood culture results...
α-Sight™ integrates advanced SPECT imaging, radiochemistry, and quantitative analysis to enable precise tracking of alpha-emitting therapies...
Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research...
Novel monoclonal antibody targets resolution of chronic inflammation through a differentiated therapeutic strategy...
The Spur Stent System was granted FDA De Novo clearance in a high-risk, long-lesion population...
Medivive’s NAD⁺ therapy is designed to improve bioavailability compared to oral precursors ...
Seal Shield's complete UV-C solution suite is designed to address the full spectrum of device sanitisation needs in clinical environments...
Virica and FUJIFILM Biosciences will co-develop an off-the-shelf enhancer–media solution to boost AAV yields and process robustness in FUJIFILM Biosciences BalanCD HEK293 system...
The conversation explores how this innovation is shaping the future of dermatologic oncology, where real-time imaging, AI-driven insights, and patient-centric care models converge to deliver more effective and accessible cancer treatment...
This partnership is designed to remove that bottleneck by combining Pillar's portfolio of oncoReveal NGS-based kitted panels with CellCarta's global clinical trial testing execution...
